Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Fennec Pharmaceuticals Q3 EPS $(0.31) Down From $(0.16) YoY

Fennec Pharmaceuticals Q3 EPS $(0.31) Down From $(0.16) YoY

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.31) per share. This is a 93.75 percent decrease over losses of $(0.16) per share from the same period last year.

byBenzinga Newsdesk

November 11, 2022

1 minute read

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.31) per share. This is a 93.75 percent decrease over losses of $(0.16) per share from the same period last year.

Jeffs’ Brands Acquires UK Pest Control Company For $2.5M Cash

By Shivani Kumaresan

November 23, 12:11 PM

Jeffs’ Brands Ltd (NASDAQ:JFBR) has entered into a non-binding term sheet with a company incorporated in England engaged in the sale of…

JFBR

Anixa Biosciences Announces Treatment Of Second Patient In Its Ovarian Cancer CAR-T Clinical Trial

By Benzinga Newsdesk

May 22, 8:35 AM

Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that, in conjunction with its partner Moffitt Cancer Center, it has commenced

ANIX

Dogecoin Funding Rates Turn Negative As Short Sellers Eye Further Losses

By Murtuza Merchant

June 20, 10:06 AM

Dogecoin (CRYPTO: DOGE) is beginning to see a surge in short bets as the broader meme sector experiences a downturn, raising concerns about the stability of meme co

$DOGE